| 000 | 01457 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517021120.0 | ||
| 264 | 0 | _c20150422 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1549-5477 | ||
| 024 | 7 |
_a10.1101/gad.256214.114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuillemette, Shawna | |
| 245 | 0 | 0 |
_aResistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4. _h[electronic resource] |
| 260 |
_bGenes & development _cMar 2015 |
||
| 300 |
_a489-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAutoantigens _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, BRCA2 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMi-2 Nucleosome Remodeling and Deacetylase Complex _xgenetics |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 700 | 1 | _aSerra, Ryan W | |
| 700 | 1 | _aPeng, Min | |
| 700 | 1 | _aHayes, Janelle A | |
| 700 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 700 | 1 | _aGreen, Michael R | |
| 700 | 1 | _aCantor, Sharon B | |
| 773 | 0 |
_tGenes & development _gvol. 29 _gno. 5 _gp. 489-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1101/gad.256214.114 _zAvailable from publisher's website |
| 999 |
_c24675228 _d24675228 |
||